109 related articles for article (PubMed ID: 10487548)
1. Analysis of the clinical benefit of 5-fluorouracil and radiation treatment in locally advanced pancreatic cancer.
Fisher BJ; Perera FE; Kocha W; Tomiak A; Taylor M; Vincent M; Bauman GS
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):291-5. PubMed ID: 10487548
[TBL] [Abstract][Full Text] [Related]
2. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
Crane CH; Abbruzzese JL; Evans DB; Wolff RA; Ballo MT; Delclos M; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Vauthey JN; Wong AB; Phan T; Nguyen Q; Janjan NA
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1293-302. PubMed ID: 11955742
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer.
Park JK; Ryu JK; Lee JK; Yoon WJ; Lee SH; Kim YT; Yoon YB
Pancreas; 2006 Nov; 33(4):397-402. PubMed ID: 17079946
[TBL] [Abstract][Full Text] [Related]
4. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Burris HA; Moore MJ; Andersen J; Green MR; Rothenberg ML; Modiano MR; Cripps MC; Portenoy RK; Storniolo AM; Tarassoff P; Nelson R; Dorr FA; Stephens CD; Von Hoff DD
J Clin Oncol; 1997 Jun; 15(6):2403-13. PubMed ID: 9196156
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of clinical factors and treatment results in patients with advanced pancreatic cancer.
Brasiūnas V; Brasiūniene B; Juozaityte E; Barauskas G
Medicina (Kaunas); 2004; 40(11):1074-80. PubMed ID: 15547308
[TBL] [Abstract][Full Text] [Related]
6. Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer.
Shinchi H; Takao S; Noma H; Matsuo Y; Mataki Y; Mori S; Aikou T
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):146-50. PubMed ID: 12007953
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience.
Rakhra S; Strauss JB; Robertson J; McGinn CJ; Kim T; Huang J; Blake A; Helenowski I; Hayes JP; Mulcahy M; Small W
J Gastrointest Cancer; 2016 Jun; 47(2):196-201. PubMed ID: 27112332
[TBL] [Abstract][Full Text] [Related]
8. Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas.
Wong AA; Delclos ME; Wolff RA; Evans DB; Abbruzzese JL; Tamm EP; Xiong HQ; Ho L; Crane CH;
Am J Clin Oncol; 2005 Jun; 28(3):227-33. PubMed ID: 15923793
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
[TBL] [Abstract][Full Text] [Related]
10. Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic cancer: results of feasibility study.
Bai YR; Wu GH; Guo WJ; Wu XD; Yao Y; Chen Y; Zhou RH; Lu DQ
World J Gastroenterol; 2003 Nov; 9(11):2561-4. PubMed ID: 14606097
[TBL] [Abstract][Full Text] [Related]
11. Locally advanced pancreatic cancer treated with radiation and 5-fluorouracil.
Mawdsley S; Hall M; Glynne-Jones R
Clin Oncol (R Coll Radiol); 2002 Aug; 14(4):308-12. PubMed ID: 12206644
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
13. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma.
Ishii H; Okada S; Tokuuye K; Nose H; Okusaka T; Yoshimori M; Nagahama H; Sumi M; Kagami Y; Ikeda H
Cancer; 1997 Apr; 79(8):1516-20. PubMed ID: 9118032
[TBL] [Abstract][Full Text] [Related]
14. Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic cancer.
Mehta VK; Poen JC; Ford JM; Oberhelman HA; Vierra MA; Bastidas AJ; Fisher GA
Am J Clin Oncol; 2001 Apr; 24(2):155-9. PubMed ID: 11319291
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.
Rothenberg ML; Moore MJ; Cripps MC; Andersen JS; Portenoy RK; Burris HA; Green MR; Tarassoff PG; Brown TD; Casper ES; Storniolo AM; Von Hoff DD
Ann Oncol; 1996 Apr; 7(4):347-53. PubMed ID: 8805925
[TBL] [Abstract][Full Text] [Related]
16. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil and cisplatin.
Azria D; Ychou M; Jacot W; Thezenas S; Lemanski C; Senesse P; Prost P; Delard R; Masson B; Dubois JB
Pancreas; 2002 Nov; 25(4):360-5. PubMed ID: 12409830
[TBL] [Abstract][Full Text] [Related]
17. [5-FU based chemoradiotherapy for unresectable locally advanced pancreatic cancer].
Niki T; Soejima T; Yoshikawa T; Yamamoto Y; Fujii O; Ohta Y; Tsuda M; Horita K; Tsujino K; Hirohata S; Fujino Y; Nishisaki H
Gan To Kagaku Ryoho; 2009 Jan; 36(1):63-9. PubMed ID: 19151565
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 5-FU and leucovorin to gemcitabine in the treatment of pancreatic cancer.
Klein B; Sadikov E; Mishaeli M; Levin I; Figer A
Oncol Rep; 2000; 7(4):875-7. PubMed ID: 10854561
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for resectable and advanced pancreatic cancer.
Berlin JD; Rothenberg M
Oncology (Williston Park); 2001 Oct; 15(10):1241-9, 1254; discussion 1254-64. PubMed ID: 11702956
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy in pancreatic cancer: a critical appraisal.
Oettle H; Neuhaus P
Drugs; 2007; 67(16):2293-310. PubMed ID: 17983252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
